Cargando…
Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
INTRODUCTION: To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer patients treated with hypofractionated versus conventionally fractionated (2.0 Gy relative biological e...
Autores principales: | Iizumi, Takashi, Ishikawa, Hitoshi, Sekino, Yuta, Tanaka, Keiichi, Takizawa, Daichi, Makishima, Hirokazu, Numajiri, Haruko, Mizumoto, Masashi, Nakai, Kei, Okumura, Toshiyuki, Sakurai, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163454/ https://www.ncbi.nlm.nih.gov/pubmed/34664410 http://dx.doi.org/10.1002/jmrs.551 |
Ejemplares similares
-
Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma
por: Iizumi, Takashi, et al.
Publicado: (2021) -
Proton beam therapy for hepatocellular carcinoma with bile duct invasion
por: Iizumi, Takashi, et al.
Publicado: (2023) -
Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020) -
Abnormal sensation during total body irradiation: a prospective observational study
por: Mizumoto, Masashi, et al.
Publicado: (2022) -
Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation
por: Li, Yinuo, et al.
Publicado: (2022)